Don't Add Tolvaptan (Samsca) to Improve Diuresis in HF Patients

December 2016

New evidence will bring up questions about the best way to diurese acute decompensated heart failure (ADHF) patients.

We know to give volume-overloaded patients IV loop diuretics (furosemide, etc). But side effects, such as renal dysfunction and electrolyte abnormalities, have created a push to find better options.

Hopes were set on tolvaptan (Samsca). It's used to treat severe hyponatremia by blocking vasopressin and increasing free water excretion.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote